Skip to main content
Ascletis Pharma Inc. logo

Ascletis Pharma Inc. — Investor Relations & Filings

Ticker · 1672 ISIN · KYG0520K1094 LEI · 254900SKEFCO9I3GPL05 HKEX Manufacturing
Open in API
Filings indexed 1,474 across all filing types
Latest filing 2019-04-04 Share Issue/Capital Cha…
Country KY Cayman Islands
Listing HKEX 1672

About Ascletis Pharma Inc.

http://www.ascletis.com

Ascletis Pharma Inc. is a fully integrated, R&D driven biotechnology company dedicated to the development and commercialization of potential best-in-class and first-in-class therapeutics. The company covers the entire value chain from discovery to sales. Ascletis primarily focuses on metabolic diseases, including chronic weight management, utilizing proprietary platforms such as Artificial Intelligence-assisted Structure-Based Drug Discovery (AISBDD), Ultra-Long-Acting Platform (ULAP), and Peptide Oral Transport ENhancement Technology (POTENT). Key pipeline candidates include ASC30 (oral/subcutaneous GLP-1R agonist), ASC35 (GLP-1R/GIPR dual agonist), ASC36 (amylin receptor agonist), and ASC37 (GLP-1R/GIPR/GCGR triple agonist). The company also maintains active programs in viral diseases, NASH/PBC, and oncology.

Recent filings

Filing Released Lang Actions
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2019
Share Issue/Capital Change Classification · 95% confidence The document is titled 'Monthly Return of Equity Issuer on Movements in Securities' for the month ended 31/3/2019, submitted to the Hong Kong Exchanges and Clearing Limited. It details movements in authorized and issued share capital, share options, warrants, convertibles, and other share-related transactions during the month. The content is focused on share capital changes and related confirmations, without financial performance data, earnings, management commentary, or legal proceedings. It is a regulatory disclosure about share capital movements rather than a financial report or announcement of a report. This type of document fits best under 'Share Issue/Capital Change' (SHA) as it reports on changes in share capital and related securities.
2019-04-04 English
Monthly Return of Equity Issuer on movements in Securities for the month ended 31 March 2019
Regulatory Filings Classification · 95% confidence The document is titled 'Monthly Return of Equity Issuer on Movements in Securities' for the month ended 31/3/2019, submitted to the Hong Kong Exchanges and Clearing Limited. It details movements in authorised share capital, issued share capital, share options, warrants, convertibles, and other share-related transactions. The content focuses on changes in share capital and securities movements rather than financial performance, earnings, or management commentary. It is a regulatory filing reporting share capital movements for a specific month, typical of a regulatory compliance disclosure rather than a financial report or announcement of voting results. The document length is substantial (13,529 characters) and contains detailed data, not just an announcement or certification. Therefore, the best fitting category is Regulatory Filings (RNS), as it is a general regulatory announcement about share capital movements that does not fit into more specific categories like Share Issue/Capital Change (SHA) or Transaction in Own Shares (POS) because it covers a broad range of share capital movements and is a monthly return report to the exchange.
2019-04-01 English
RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 2018
Annual Report Classification · 100% confidence The document is titled "RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 2018" and contains detailed audited consolidated financial results, including comprehensive financial statements such as the consolidated statement of profit or loss, statement of financial position, notes to the consolidated financial statements, segment information, and application of new accounting standards. The document covers a full fiscal year ending December 31, 2018, and includes comparative figures for the previous year. The length of the document (15,000 characters) and the presence of detailed financial data and notes indicate this is the full annual financial report rather than a brief announcement or summary. There is no indication that this is merely an announcement of a report or a certification. Therefore, this document fits the definition of an Annual Report (10-K equivalent). FY 2018
2019-03-27 English
POSITIVE PROFIT ALERT
Regulatory Filings Classification · 95% confidence The document is titled 'POSITIVE PROFIT ALERT' and is an announcement made pursuant to the Listing Rules of the Hong Kong Stock Exchange. It provides a preliminary assessment of the company's unaudited consolidated management accounts for the year ended 31 December 2018, indicating an expected net profit. It explicitly states that the final audited results are not yet available and will be published later. The document is short (3246 characters) and serves as an early profit warning rather than a full financial report. It does not contain detailed financial statements or comprehensive analysis, but rather a notification to shareholders and investors about expected positive results. This fits the profile of a Regulatory Filing (RNS) as it is a regulatory announcement providing material information but not the full annual report or earnings release.
2019-03-25 English
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2018
Annual Report Classification · 95% confidence The document is titled 'ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2018' and contains detailed financial highlights, business review, product pipeline, and management discussion and analysis for the full fiscal year 2018. It includes audited consolidated annual results, revenue, profit/loss figures, and comprehensive narrative on business operations and product development. The length is substantial (15,000 characters), and the content is consistent with a full annual report rather than a brief announcement or summary. There is no indication that this is merely an announcement of a report or a certification. Therefore, the document fits the definition of an Annual Report (10-K). FY 2018
2019-03-24 English
DATE OF BOARD MEETING
Report Publication Announcement Classification · 95% confidence The document is an announcement from the company about the date of a board meeting where the final results for the year ended 31 December 2018 will be approved and a final dividend considered. It does not contain any financial data or the actual report itself, but rather informs about the upcoming board meeting and the expected release of results. The document length is short (1634 characters) and it is clearly an announcement, not the report. Therefore, according to the 'Menu vs Meal' rule, this is a Report Publication Announcement (RPA).
2019-03-13 English

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.